| Date | Description |
|---|
| 2024-12-20 |
insert cfo Reto Suter |
| 2024-12-20 |
insert otherexecutives Marcel Imwinkelried |
| 2024-12-20 |
insert otherexecutives Reto Suter |
| 2024-12-20 |
update person_title Marcel Imwinkelried: Member of Executive Comittee; Chief Executive Officer => Member of the Executive Committee; Chief Executive Officer and COO Drug Products Ad Interim; CEO |
| 2024-12-20 |
update person_title Reto Suter: Member of Executive Comittee; Chief Financial Officer and COO Drug Products Ad Interim => Member of the Executive Committee; Chief Financial Officer |
| 2024-10-18 |
delete cfo Reto Suter |
| 2024-10-18 |
update person_title Reto Suter: Member of Executive Comittee; Chief Financial Officer => Member of Executive Comittee; Chief Financial Officer and COO Drug Products Ad Interim |
| 2024-09-17 |
insert ceo Marcel Imwinkelried |
| 2024-09-17 |
insert cfo Reto Suter |
| 2024-09-17 |
update person_title Marcel Imwinkelried: Member of Executive Comittee; Chief Operating Officer Drug Products => Member of Executive Comittee; Chief Executive Officer |
| 2024-09-17 |
update person_title Reto Suter: Member of Executive Comittee; Chief Executive Officer Ad Interim and Chief Financial Officer => Member of Executive Comittee; Chief Financial Officer |
| 2024-06-11 |
delete ceo Wolfgang Wienand |
| 2024-06-11 |
delete cfo Reto Suter |
| 2024-06-11 |
delete person Wolfgang Wienand |
| 2024-06-11 |
update person_title Reto Suter: Member of Executive Comittee; Chief Financial Officer => Member of Executive Comittee; Chief Executive Officer Ad Interim and Chief Financial Officer |
| 2023-09-24 |
insert otherexecutives Henrik Krüpper |
| 2023-09-24 |
insert person Henrik Krüpper |
| 2023-09-24 |
update person_title Marcel Imwinkelried: Marcel Imwinkelried Chief Operating Officer Drug Products / Chief Operating Officer Drug Substances ( Ad Interim ); Member of the Executive Committee; Chief Operating Officer Drug Products / Chief Operating Officer Drug Substances ( Ad Interim ) => Member of the Executive Committee; Marcel Imwinkelried Chief Operating Officer Drug Products; Chief Operating Officer Drug Products / Chief Operating Officer Drug Substances ( Ad Interim ) |
| 2023-07-18 |
delete chro Arnoud Middel |
| 2023-07-18 |
delete otherexecutives Arnoud Middel |
| 2023-07-18 |
delete otherexecutives Colin Bond |
| 2023-07-18 |
insert chro Irene Wosgien |
| 2023-07-18 |
insert otherexecutives Christian Dowdeswell |
| 2023-07-18 |
insert otherexecutives Elodie Cingari |
| 2023-07-18 |
delete person Arnoud Middel |
| 2023-07-18 |
delete person Colin Bond |
| 2023-07-18 |
insert person Christian Dowdeswell |
| 2023-07-18 |
insert person Elodie Cingari |
| 2023-07-18 |
update person_description Isabelle Welton => Isabelle Welton |
| 2023-07-18 |
update person_title Irene Wosgien: Member of the Executive Committee; Chief Operating Officer Drug Substances => Member of the Executive Committee; Chief Human Resources Officer |
| 2023-07-18 |
update person_title Marcel Imwinkelried: Member of the Executive Committee; Marcel Imwinkelried Chief Operating Officer Drug Products; Chief Operating Officer Drug Products => Marcel Imwinkelried Chief Operating Officer Drug Products / Chief Operating Officer Drug Substances ( Ad Interim ); Member of the Executive Committee; Chief Operating Officer Drug Products / Chief Operating Officer Drug Substances ( Ad Interim ) |
| 2023-07-18 |
update person_title Marianne Späne: Member of the Executive Committee; Chief Business Officer => Member of the Executive Committee; Chief Business Officer Drug Products |
| 2022-09-29 |
delete personal_emails ch..@siegfried.ch |
| 2022-09-29 |
insert personal_emails pe..@siegfried.ch |
| 2022-09-29 |
delete person Christa Brügger |
| 2022-09-29 |
insert person Peter Stierli |
| 2022-05-07 |
delete otherexecutives Reto A. Garzetti |
| 2022-05-07 |
delete personal_emails mi..@siegfried.ch |
| 2022-05-07 |
insert otherexecutives Dr. Alexandra Brand |
| 2022-05-07 |
insert otherexecutives Dr. Beat Walti |
| 2022-05-07 |
insert otherexecutives Marcel Imwinkelried |
| 2022-05-07 |
insert personal_emails ch..@siegfried.ch |
| 2022-05-07 |
delete person Miriam Anton |
| 2022-05-07 |
delete person Reto A. Garzetti |
| 2022-05-07 |
insert person Christa Brügger |
| 2022-05-07 |
insert person Dr. Alexandra Brand |
| 2022-05-07 |
insert person Dr. Beat Walti |
| 2022-05-07 |
insert person Marcel Imwinkelried |
| 2022-05-07 |
update person_title Arnoud Middel: Global Head Human Resources Global; Member of the Executive Committee; Chief Human Resources Officer => Member of the Executive Committee; Chief Human Resources Officer |
| 2022-05-07 |
update person_title Irene Wosgien: Member of the Executive Committee; Global Head Technical Operations Drug Substances; Chief Operating Officer Drug Substances => Member of the Executive Committee; Chief Operating Officer Drug Substances |
| 2021-06-24 |
insert otherexecutives Marianne Spaene |
| 2021-06-24 |
insert person Marianne Spaene |
| 2021-04-08 |
update person_description Martin Schmid => Martin Schmid |
| 2021-04-08 |
update person_description Ulla Schmidt => Ulla Schmidt |
| 2020-05-09 |
delete otherexecutives Rudolf Hanko |
| 2020-05-09 |
insert otherexecutives Isabelle Welton |
| 2020-05-09 |
delete person Rudolf Hanko |
| 2020-05-09 |
insert person Isabelle Welton |
| 2019-07-11 |
insert otherexecutives Jürgen Roos |
| 2019-07-11 |
insert otherexecutives Rudolf Hanko |
| 2019-07-11 |
insert person Jürgen Roos |
| 2019-07-11 |
insert person Rudolf Hanko |
| 2018-04-01 |
delete person Marianne Spaene |
| 2018-04-01 |
update person_description Wolfgang Wienand => Wolfgang Wienand |
| 2017-10-28 |
insert personal_emails re..@siegfried.ch |
| 2017-05-24 |
delete cfo Michael Huesler |
| 2017-05-24 |
delete otherexecutives Thomas Villiger |
| 2017-05-24 |
insert cfo Reto Suter |
| 2017-05-24 |
delete person Michael Huesler |
| 2017-05-24 |
delete person Thomas Villiger |
| 2017-05-24 |
insert person Reto Suter |
| 2017-05-24 |
update person_description René Imwinkelried => René Imwinkelried |
| 2017-05-24 |
update person_description Wolfgang Wienand => Wolfgang Wienand |
| 2017-04-06 |
delete personal_emails mi..@siegfried.ch |
| 2017-04-06 |
update person_description Arnoud Middel => Arnoud Middel |
| 2017-04-06 |
update person_description Colin Bond => Colin Bond |
| 2017-04-06 |
update person_description Martin Schmid => Martin Schmid |
| 2017-04-06 |
update person_description Ulla Schmidt => Ulla Schmidt |
| 2017-04-06 |
update person_description Wolfgang Wienand => Wolfgang Wienand |
| 2017-04-06 |
update person_description Wolfram Carius => Wolfram Carius |
| 2016-08-25 |
update person_description Colin Bond => Colin Bond |
| 2015-10-22 |
insert otherexecutives Danielle Morelli-Blevins |
| 2015-10-22 |
delete person Dr. Christoph Becker |
| 2015-10-22 |
insert person Aaron Mercier |
| 2015-10-22 |
insert person Danielle Morelli-Blevins |
| 2015-10-22 |
insert person Dr. Maurits Janssen |
| 2015-10-22 |
insert person Europe Exclusive Synthesis |
| 2015-10-22 |
insert person Helena Klipan |
| 2015-08-27 |
delete person Dr. Frieder Mitzel |
| 2015-08-27 |
insert person Dr. Marco Henneböhle |
| 2015-07-30 |
delete person Sandra Pisek |
| 2015-04-29 |
update person_title Felix K. Meyer: Vice Chairman, Siegfried Holding AG; Vice Chairman of the Board of Directors => Vice Chairman; Vice Chairman of the Board of Directors |
| 2015-03-03 |
update person_description Dr. Thomas Villiger => Dr. Thomas Villiger |
| 2015-03-03 |
update person_description Reto A. Garzetti => Reto A. Garzetti |
| 2015-03-03 |
update person_title Dr. Wolfgang Wienand: Member of the Executive Committee; Head Strategy and Mergers & Acquisitions => Head Strategy and M & a, Legal & IP, Regulatory Affairs; Member of the Executive Committee; Head Strategy and Mergers & Acquisitions |
| 2014-12-04 |
delete person Dr. Michael Quirmbach |
| 2014-12-04 |
insert person Andrea Como |
| 2014-12-04 |
insert person Dr. Christoph Becker |
| 2014-11-06 |
delete personal_emails zh..@siegfried.cn |
| 2014-07-26 |
delete person Ko-Lin Feng |
| 2014-05-30 |
insert vp Sandy Cernick |
| 2014-05-30 |
insert person Susanne Morgenthaler |
| 2014-05-30 |
update person_title Dr. Bernd Schweigert: Business Development Manager Drug Products => Director Business Development Drug Products |
| 2014-05-30 |
update person_title Dr. Craig Douglas: Director Business Development Portfolio Products / USA => Senior Vice President / Head Business Development |
| 2014-05-30 |
update person_title Dr. Eva Mössl: Business Development Manager Exclusives => Vice President Senior Key Account Management |
| 2014-05-30 |
update person_title Dr. Frieder Mitzel: Business Development Manager Exclusives => Director Business Development Drug Substance Exclusives EU |
| 2014-05-30 |
update person_title Dr. Michael Quirmbach: Business Development Manager Exclusives => Vice President / Head Business Development |
| 2014-05-30 |
update person_title Dr. Richard W. Fengl: Business Development Manager Exclusives => Director Business Development Drug Substance US |
| 2014-05-30 |
update person_title Ed W. Lefler: Business Development Manager Exclusives and Portfolio Products => Director Business Development Drug Substance US |
| 2014-05-30 |
update person_title Ko-Lin Feng: Business Development Manager => Business Development Manager Portfolio Products |
| 2014-05-30 |
update person_title Marianne Spaene: Member of the Executive Committee; Head of Business Development; Head Business Development & Sales => Member of the Executive Committee; Head of Business Development; Head Business Development & Sales; Executive Vice President / Global Head Business Development |
| 2014-05-30 |
update person_title Sandra Pisek: Business Development Manager Drug Products => Director Business Development Drug Product |
| 2014-05-30 |
update person_title Sandy Cernick: Director Business Development Exclusives / USA => Vice President |
| 2014-05-30 |
update person_title Stephan Bregy: Director Business Development Portfolio Products => Vice President / Head Product Portfolio Business Drug Substance Portfolio EU |
| 2014-05-30 |
update person_title Urs Zeugin: Business Development Manager Portfolio Products => Director Business Development Drug Substance Portfolio EU |
| 2014-03-31 |
insert otherexecutives Wolfram Carius |
| 2014-03-31 |
insert person Wolfram Carius |
| 2013-12-29 |
insert personal_emails zh..@siegfried.cn |
| 2013-12-01 |
update person_title Dr. Bernd Schweigert: Business Development Manager Portfolio Products => Business Development Manager Drug Products |
| 2013-12-01 |
update person_title Sandra Pisek: Business Development Manager Portfolio Products => Business Development Manager Drug Products |
| 2013-11-03 |
delete person Frau Michele Seah |
| 2013-05-20 |
insert otherexecutives Colin Bond |
| 2013-05-20 |
delete person Lindsey A. Pruitt |
| 2013-05-20 |
insert person Colin Bond |
| 2013-05-20 |
update person_description Andreas Casutt => Andreas Casutt |
| 2013-05-20 |
update person_description Felix K. Meyer => Felix K. Meyer |
| 2013-05-20 |
update person_title Peter A. Gehler: Member of the Executive Committee; Head Corporate Center, Siegfried Ltd. and Secretary to the Board of Directors, Siegfried Holding AG; Chief Communications Officer of the Siegfried Group => Member of the Executive Committee; Head Corporate Center, Siegfried Ltd.; Chief Communications Officer of the Siegfried Group; Head Corporate Center |
| 2013-05-20 |
update person_title Stephan Bregy: Business Development Manager Portfolio Products => Director Business Development Portfolio Products |